The cannabis industry has experienced a technological revolution in recent years, with the integration of Industry 4.0 technologies throughout its value chain. Professionals in...
CASA technical staff have filed for protected industrial action, citing concerns over staffing levels and training.
Unions have pointed to a 2022 Australian National Audit...
Starting last year the FDA has focused much of its cell therapy oversight resources on birth-related firms, including both clinics and suppliers. The latest...